Q & A

Read the latest PLC CEO interviews. CEO’s from UK listed PLC’s, Analysts and Fund Managers answering questions about their business.

Goodbody Health’s value to users will be reassurance to enable them to take control of their own health (AQSE:GDBY)

Goodbody Health Inc (AQSE:GDBY) Scientific Advisory Committee Member Dr Jamie Brosch caught up with DirectorsTalk for an exclusive interview to discuss his background as a GP, how the company’s partnership..

CyanConnode “immense revenue opportunity in India” says Hardman & Co (LON:CYAN)

CyanConnode Holdings plc (LON:CYAN) is the topic of conversation when Hardman and Co’s Technology Analyst Milan Radia caught up with DirectorsTalk for an exclusive interview. Q1: We’ve spoken about CyanConnode..

City of London Investment Group delivers a strong dividend and very strong robust earnings stream says Zeus Capital (LON:CLIG)

City of London Investment Group plc (LON:CLIG) is the topic of conversation when Zeus Capital’s Research Director Robin Savage caught up with DirectorsTalk for an exclusive interview. Q1: City of..

Helium One expecting another transformational year in 2022 (LON:HE1)

Helium One Global Ltd (LON:HE1) Chief Executive Officer David Minchin caught up with DirectorsTalk for an exclusive interview to discuss 2021 achievements, the exploration programme, what investors should be looking..

Aferian enhancing the value that they deliver for customers (LON:AFRN)

Aferian plc (LON:AFRN) Chief Executive Officer Donald McGarva caught up with DirectorsTalk for an exclusive interview to discuss group performance in 2021, progress in its 2025 strategy goals, what we..

Zinc Media Group’s content creation areas all showing signs of growth (LON:ZIN)

Zinc Media Group plc (LON:ZIN) Chief Executive Officer Mark Browning caught up with DirectorsTalk for an exclusive interview to discuss what the company does, its typical clients, highlights from their..

Fidelity Japan Trust long-term record of outperforming UK markets and Japanese benchmarks (LON:FJV)

Fidelity Japan Trust plc (LON:FJV) is the topic of conversation when Hardman and Co’s Analyst Mark Thomas caught up with DirectorsTalk for an exclusive interview. Q1: You called your recent..

CentralNic Group 2022 revenue and EBITDA forecasts upgraded by Zeus Capital (LON:CNIC)

CentralNic Group plc (LON:CNIC) is the topic of conversation when Zeus Capital’s Technology Analyst Bob Liao caught up with DirectorsTalk for an exclusive interview. Q1: CentralNic Group announced a strong..

Cizzle Biotechnology significantly increased ability to bring money and value to shareholders (LON:CIZ)

Cizzle Biotechnology Holdings plc (LON:CIZ) Executive Chairman Allan Syms caught up with DirectorsTalk for an exclusive interview to discuss acquiring 5% economic interest of AZD 1656, what it is and..

Dekel Agri-Vision strong start to the year with more high season big months to come (LON:DKL)

Dekel Agri-Vision plc (LON:DKL) Executive Director Lincoln Moore caught up with DirectorsTalk for an exclusive interview to discuss the strong start to the high season, strong CPO prices, why PKO..

Vector Capital revenue going to be ahead of market expectations (LON:VCAP)

Vector Capital plc (LON:VCAP) Chief Executive Officer Agam Jain caught up with DirectorsTalk for an exclusive interview to discuss what the company does, products & services it offers, highlights from,..

Goodbody Health’s PhytoVista in a good place in terms of meeting current and future regulatory requirements (AQSE:GDBY)

Goodbody Health Group Inc (AQSE:GDBY) subsidiary PhytoVista Laboratories Chief Scientific Officer Nick Clarkson caught up with DirectorsTalk for an exclusive interview to discuss the extension of the scope of ISO..

itim Group CEO “very optimistic for the prospects for the business” (LON:ITIM)

itim Group plc (LON:ITIM) Founder and Chief Executive Officer Ali Athar caught up with DirectorsTalk for an exclusive interview to discuss what the company does, its typical customers, its impressive..

Cadence Minerals first phase of investment in Amapá completes (LON:KDNC)

Cadence Minerals plc (LON:KDNC) Chief Executive Officer Kiran Morzaria caught up with DirectorsTalk for an exclusive interview to discuss the completion of phase one of their investment in the Amapá..

Strix Group share price “could bounce back as we get strong earnings this year “says Zeus Capital (LON:KETL)

Strix Group plc (LON:KETL) is the topic of conversation when Zeus Capital’s Research Director Andy Hanson caught up with DirectorsTalk for an exclusive interview. Q1: Strix Group have released a..

Cizzle Biotechnology commercial & royalty agreement represents a very significant deal for the company (LON:CIZ)

Cizzle Biotechnology Holdings plc (LON:CIZ) Executive Chairman Allan Syms caught up with DirectorsTalk for an exclusive interview to discuss the commercial and royalty agreement to develop and market their early..

Open Orphan open for business to deal with big pharma and biotechs (LON:ORPH)

Open Orphan plc (LON:ORPH) Executive Chairman Cathal Friel caught up with DirectorsTalk for an exclusive interview to discuss the results from the COVID-19 characterisation study, the next phase of the..

Tirupati Graphite growth and momentum to continue (LON:TGR)

Tirupati Graphite plc (LON:TGR) Executive Chairman and Managing Director Shishir Poddar caught up with DirectorsTalk for an exclusive interview to discuss hitting production targets and what it’ll mean for the..

Quadrise Fuels International test results will support and hopefully accelerate the plans on the larger scale trials (LON:QFI)

Quadrise Fuels International plc (LON:QFI) Chief Executive Officer Jason Miles caught up with DirectorsTalk for an exclusive interview to discuss new Chairman Andy Morrison, the significant for bioMSAR as a..

Fintel doing well, both financially and operationally says Zeus Capital

Fintel plc (LON:FNTL) is the topic of conversation when Zeus Capital’s Research Analyst Robin Savage caught up with DirectorsTalk for an exclusive interview. Q1: Robin, what were the key points..

Search

Funds

Q & A

Search

Funds

Q & A

FTSE 100

Funds